Understanding how binge drinking affects blood pressure in middle-aged adults
Reducing blood pressure in mid-life adult binge drinkers: the role of microvascular function and sympathetic activity
This study is looking at how binge drinking affects blood pressure and heart health in adults aged 50 to 64, and it aims to find better ways to help people in this age group manage the risks of drinking too much alcohol.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Texas Arlington NIH-funded |
| Lab location | 1 site (Arlington, United States) |
| Project ID | NIH-11066648 on NIH RePORTER |
What this research studies
This research investigates the relationship between binge drinking and high blood pressure in mid-life adults aged 50-64. It aims to understand how binge drinking impacts microvascular function and sympathetic nerve activity, which are crucial for cardiovascular health. The study will involve training and developing new strategies to address the health risks associated with alcohol consumption in this age group. By focusing on this often-overlooked demographic, the research seeks to fill knowledge gaps and improve health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are mid-life adults aged 50-64 who engage in binge drinking and may have elevated blood pressure.
Not a fit: Patients who do not binge drink or are outside the age range of 50-64 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention and treatment strategies for hypertension in binge drinkers.
How similar studies have performed: Previous research has shown that addressing alcohol-related health issues can lead to significant improvements in cardiovascular health, indicating potential success for this approach.
Where this research is happening
Arlington, United States
- University of Texas Arlington — Arlington, United States (Active)
Researchers
- Principal investigator: Hwang, Chueh-Lung — University of Texas Arlington
- Study coordinator: Hwang, Chueh-Lung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.